These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32079250)

  • 1. Modeling Human Cytomegalovirus in Humanized Mice for Vaccine Testing.
    Koenig J; Theobald SJ; Stripecke R
    Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32079250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34
    Theobald SJ; Khailaie S; Meyer-Hermann M; Volk V; Olbrich H; Danisch S; Gerasch L; Schneider A; Sinzger C; Schaudien D; Lienenklaus S; Riese P; Guzman CA; Figueiredo C; von Kaisenberg C; Spineli LM; Glaesener S; Meyer-Bahlburg A; Ganser A; Schmitt M; Mach M; Messerle M; Stripecke R
    Front Immunol; 2018; 9():2734. PubMed ID: 30524448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.
    Kiener R; Fleischmann M; Wiegand MA; Lemmermann NAW; Schwegler C; Kaufmann C; Renzaho A; Thomas S; Felder E; Niller HH; Asbach B; Wagner R
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Stern L; Withers B; Avdic S; Gottlieb D; Abendroth A; Blyth E; Slobedman B
    Front Microbiol; 2019; 10():1186. PubMed ID: 31191499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting viral natural history for vaccine development.
    Barry PA
    Med Microbiol Immunol; 2015 Jun; 204(3):255-62. PubMed ID: 25794555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and Functional Differences between Human Herpesvirus 6- and Human Cytomegalovirus-Specific T Cells.
    Fastenackels S; Bayard C; Larsen M; Magnier P; Bonnafous P; Seddiki N; Appay V; Gautheret-Dejean A; Sauce D
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
    Yue Y; Barry PA
    Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel vaccines against human cytomegalovirus.
    Cui X; Snapper CM
    Hum Vaccin Immunother; 2019; 15(11):2673-2683. PubMed ID: 31017831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus.
    Luganini A; Terlizzi ME; Gribaudo G
    Front Microbiol; 2016; 7():715. PubMed ID: 27242736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
    Gerna G; Lilleri D
    New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction of Human Cytomegalovirus Infection by Galectin-9.
    Machala EA; Avdic S; Stern L; Zajonc DM; Benedict CA; Blyth E; Gottlieb DJ; Abendroth A; McSharry BP; Slobedman B
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30487283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
    Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
    J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.
    Wu Z; Frascaroli G; Bayer C; Schmal T; Mertens T
    J Virol; 2015 Jun; 89(12):6435-41. PubMed ID: 25855747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
    Wu Z; Sinzger C; Reichel JJ; Just M; Mertens T
    J Virol; 2015 Mar; 89(5):2906-17. PubMed ID: 25540381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.